Acute Sinusitis: Symptoms, Causes, Diagnosis and Treatment | Nasodren®

Acute sinusitis (acute rhinosinusitis, ARS) is sudden-onset inflammation of the nasal mucosa and paranasal sinuses lasting less than 4 weeks. Viral upper respiratory infection causes 90–98% of acute sinusitis cases. The 3 clinical subtypes of acute rhinosinusitis are viral rhinosinusitis (VRS), post-viral rhinosinusitis (PVRS), and acute bacterial rhinosinusitis (ABRS). Acute sinusitis affects approximately 12% of adults in the United States annually, according to the 2025 American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) Clinical Practice Guideline update authored by Payne and colleagues. Of viral upper respiratory infections in adults, 0.5–2% are complicated by acute bacterial rhinosinusitis; in children, 6–13% progress to bacterial infection. Sinusitis remains the 5th most common diagnosis for which antibiotics are prescribed.

The 3 primary guideline references for acute rhinosinusitis management are EPOS 2012 (European Position Paper on Rhinosinusitis and Nasal Polyps), the AAO-HNS 2025 Clinical Practice Guideline update (Payne et al., Otolaryngology–Head and Neck Surgery, July 2025), and the Infectious Diseases Society of America (IDSA) 2012 Clinical Practice Guideline (Chow et al., Clinical Infectious Diseases). Nasodren® (Cyclamen europaeum extract nasal spray) is the only natural treatment included in the EPOS 2012 European rhinosinusitis guidelines with a Level A recommendation.

What Is Acute Sinusitis?

Acute sinusitis is sudden-onset inflammation of the paranasal sinus mucosa lasting less than 4 weeks, with complete resolution of symptoms between episodes. The preferred medical term is acute rhinosinusitis (ARS), because the nasal mucosa is always simultaneously involved in sinus inflammation. EPOS 2012 and AAO-HNS both use “rhinosinusitis” as the standard nomenclature.

The duration criterion separates acute rhinosinusitis from subacute rhinosinusitis (4–12 weeks) and chronic rhinosinusitis (≥12 weeks). Harvard Health defines acute sinusitis as lasting 3 weeks or less, with no more than 3 episodes per year.

There are 3 causative subtypes of acute rhinosinusitis:

1. Viral rhinosinusitis (VRS) — triggered by the common cold; accounts for 90–98% of all ARS cases
2. Post-viral rhinosinusitis (PVRS) — symptoms persist beyond 10 days after a viral upper respiratory infection, without confirming bacterial aetiology
3. Acute bacterial rhinosinusitis (ABRS) — develops in 0.5–2% of viral upper respiratory infections in adults and 6–13% in children

Acute rhinosinusitis affects approximately 12% of adults in the United States annually (AAO-HNS 2025 CPG update, Payne et al.). In the United Kingdom, 3 in 1,000 people are affected annually by acute sinusitis, while chronic sinusitis affects 1 in 1,000. Spontaneous resolution occurs in 46% of patients after 1 week and 64% after 2 weeks without treatment, according to the Lemiengre systematic review referenced in the AAO-HNS 2025 guideline. The economic burden of sinusitis in the United States reached approximately $3.39 billion in 1996, with an additional $1.77 billion per year for paediatric cases (National Ambulatory Medical Care Survey data).

What Are the Symptoms of Acute Sinusitis?

The 4 cardinal symptoms of acute rhinosinusitis, as defined by EPOS 2012, are nasal blockage or congestion, nasal discharge (rhinorrhea), facial pain or pressure, and reduction or loss of smell. A clinical diagnosis of ARS requires 2 or more of these symptoms, with nasal blockage or rhinorrhea being mandatory (EPOS 2012 diagnostic rule).

Each cardinal symptom has a distinct pathophysiological mechanism:

1. Nasal blockage or congestion — mucosal oedema obstructs nasal airflow, impairs breathing, sleep quality, and olfaction
2. Nasal discharge (rhinorrhea) — anterior discharge from the nostrils or posterior discharge (post-nasal drip) into the throat; thick, yellow-green in ABRS; clear in VRS
3. Facial pain or pressure — trigeminal nerve stimulation from inflammatory mediators including bradykinin and prostaglandins, combined with mechanical pressure from retained mucus
4. Reduced or lost smell (hyposmia or anosmia) — physical obstruction of airflow to the olfactory epithelium from inflammatory oedema

Additional symptoms of acute sinusitis include headache (the most common patient complaint), fever (present in ABRS, less common in VRS), bad breath (halitosis from bacterial mucus), cough (from post-nasal drip), ear fullness or pressure (Eustachian tube obstruction), fatigue, malaise, and dental pain (especially upper molars, due to maxillary sinus proximity). Cacosmia — a foul-smelling odour detected by the patient — has the highest positive likelihood ratio (+LR 4.3) for ABRS diagnosis (Annals of Family Medicine, 2019; AAFP, 2020).

Acute Sinusitis Symptoms by Sinus Location

Acute sinusitis symptoms vary by which paranasal sinus is inflamed. The 4 sinus locations produce distinct pain patterns, and symptom localisation helps identify the affected sinus.

Sinus	Location	Primary Pain Site	Characteristic Signs
Maxillary	Cheekbones	Cheek, below eyes, upper teeth	Pain worsens bending forward; toothache
Frontal	Forehead	Forehead above eyebrows	Pain worsens lying flat on back
Ethmoid	Between eyes	Bridge of nose, behind/between eyes	Eyelid swelling; loss of smell
Sphenoid	Behind eyes	Back of head, top of head, behind eyes	Earache; neck pain; deep headache

The maxillary sinuses are the most commonly infected paranasal sinuses because they have the largest volume and drain upward against gravity, making them more susceptible to mucus retention and bacterial colonisation (Harvard Health, April 2026; EPOS 2012).

What Causes Acute Sinusitis?

Acute sinusitis is caused by viral infection in 90–98% of cases. Bacterial superinfection, fungal infection, allergic inflammation, and structural obstruction account for the remaining cases.

Infective Causes

Viral pathogens cause the vast majority of acute rhinosinusitis. Rhinovirus is the most common viral trigger, followed by adenovirus, coronavirus, influenza virus, and parainfluenza virus. These viruses cause 90–98% of ARS in adults.

Bacterial pathogens responsible for ABRS include Streptococcus pneumoniae (20–43% of cases), Haemophilus influenzae (22–35%), and Moraxella catarrhalis (2–10%), according to the IDSA 2012 Clinical Practice Guideline (Chow et al., Clinical Infectious Diseases). Staphylococcus aureus accounts for a smaller proportion of cases.

Fungal sinusitis, caused primarily by Aspergillus fumigatus, is rare and occurs mainly in immunocompromised patients. Fungal sinusitis is classified as invasive or non-invasive depending on tissue invasion.

Structural and Anatomical Causes

Structural obstruction of the ostiomeatal complex (OMC) predisposes to acute sinusitis. A deviated nasal septum misdirects airflow and impairs OMC drainage. Nasal polyps physically obstruct the ostiomeatal complex. Concha bullosa (pneumatised middle turbinate) reduces nasal airway space. Foreign bodies, especially in children, cause unilateral obstruction and infection. Dental root infections cause odontogenic maxillary sinusitis, accounting for 40–50% of some maxillary sinusitis cohorts.

Inflammatory and Systemic Causes

Allergic rhinitis causes mucosal oedema that blocks sinus ostia; 60–80% of chronic rhinosinusitis patients also have allergic rhinitis. Aspirin-exacerbated respiratory disease (AERD) is included in the 2025 AAO-HNS guideline update as a recognised sinusitis risk factor. Immune deficiency conditions including HIV, diabetes, chemotherapy, cystic fibrosis, and primary ciliary dyskinesia impair mucosal defence. GLP-1 receptor agonist medications show an emerging association with sinusitis (Medscape, 2026).

The Common Cold to Acute Sinusitis Progression

The common cold progresses to acute bacterial sinusitis in 4 steps:

1. Viral upper respiratory infection causes nasal mucosal oedema
2. Mucosal swelling occludes the ostiomeatal complex (OMC)
3. Sinus drainage fails; mucus accumulates in the paranasal sinuses
4. Stagnant mucus enables bacterial multiplication, and ABRS develops in 0.5–2% of viral rhinosinusitis cases

Viral vs Bacterial Acute Sinusitis: Key Differences

Distinguishing viral from bacterial acute sinusitis determines whether antibiotics are appropriate. The single most reliable differentiator is symptom duration, not discharge colour.

Feature	Viral ARS (VRS)	Bacterial ARS (ABRS)
Prevalence	90–98% of ARS	0.5–2% in adults; 6–13% in children
Duration	<10 days; improving	>10 days without improvement OR double worsening
Nasal discharge colour	Starts clear; may turn yellow-green	Yellow-green; colour alone not diagnostic
Fever	Common early; resolves	May persist or recur
Treatment	Watchful waiting; Nasodren®; supportive care	Amoxicillin with or without clavulanate (after watchful waiting)

The AAFP (2020), AAO-HNS 2025, and EPOS 2012 all confirm that discharge colour alone cannot distinguish viral from bacterial rhinosinusitis. Cacosmia (a foul-smelling odour perceived by the patient) has the highest positive likelihood ratio (+LR 4.3, 95% CI derived from a Danish study of 175 adult patients) for ABRS. Tooth pain (+LR 2.0) and purulent nasal discharge (+LR 1.3) provide additional diagnostic indicators. Clinical impression (+LR 3.9) remains the single strongest physician predictor.

Double-worsening — symptoms improving then returning worse — is the strongest clinical ABRS indicator (AAO-HNS 2025; IDSA 2012).

Who Gets Acute Sinusitis? Risk Factors and Prevalence

Acute sinusitis affects approximately 12% of adults in the United States annually (AAO-HNS 2025 CPG update, Payne et al.). 9 primary risk factors increase the likelihood of developing acute sinusitis.

1. Recent viral upper respiratory infection — the common cold is the primary trigger for 90–98% of ARS cases
2. Allergic rhinitis — blocks OMC drainage and increases sinusitis susceptibility
3. Nasal polyps or deviated nasal septum — anatomical obstruction prevents sinus drainage
4. Asthma — the “one airway” theory describes a shared inflammatory pathway between asthma and sinusitis
5. Immune deficiency — diabetes, HIV, corticosteroid therapy, and chemotherapy impair infection resistance
6. Dental infections — cause odontogenic maxillary sinusitis through direct bacterial spread
7. Regular swimming, diving, and surfing — introduce water-borne bacteria into nasal sinuses
8. Cigarette smoking (active and passive) — impairs mucociliary clearance and delays mucus transport
9. Aspirin-exacerbated respiratory disease (AERD) — added to the 2025 AAO-HNS guideline update

Acute sinusitis is more common in females, with peak incidence at 43–64 years of age. Incidence increases in winter months compared to summer (Medscape Emedicine). The average child experiences 6–8 colds per year, and 6–13% of these infections develop into ABRS (IDSA 2012).

How Is Acute Sinusitis Diagnosed?

Acute sinusitis is a clinical diagnosis made through history and physical examination. Imaging and laboratory tests are not required for initial uncomplicated acute sinusitis.

The AAO-HNS 2025 Clinical Practice Guideline (Payne et al.) recommends that clinicians distinguish presumed ABRS from ARS caused by viral URI and non-infectious conditions. The IDSA 2012 Clinical Practice Guideline (Chow et al.) defines 3 clinical presentations that diagnose ABRS:

1. Persistent symptoms — symptoms persisting more than 10 days without improvement
2. Double-worsening — symptoms improve then worsen within 10 days (the most specific ABRS indicator)
3. Severe onset — fever of 38°C (100.4°F) or higher combined with purulent nasal discharge for 3 or more consecutive days

Diagnostic steps for acute sinusitis include:

1. Clinical history — duration, character of symptoms, cold history, prior episodes, allergy history
2. Physical examination — anterior rhinoscopy; nasal endoscopy if ENT referral is needed; palpation of sinus areas; oropharyngeal assessment for post-nasal drip
3. No imaging for uncomplicated first-episode ARS — AAO-HNS 2025 strong recommendation; NICE guidance (UK) concurs
4. CT scan — reserved for refractory or complicated ARS; suspected orbital or intracranial spread
5. Allergy testing — if allergic rhinitis is suspected as an underlying cause
6. Sinus aspirate culture — only for research or refractory ABRS; invasive; not routine clinical practice

Diagnostic tools that should not be used for initial ARS assessment include discharge colour alone (AAFP: “colour of rhinorrhea is not helpful in distinguishing bacterial from viral aetiologies”), plain X-rays (poor diagnostic accuracy; not recommended by AAO-HNS 2025 or EPOS 2012), and routine blood tests. C-reactive protein (CRP) may be useful in primary care settings according to a 2017 Danish clinical prediction rule.

How Is Acute Sinusitis Treated?

Treatment of acute sinusitis targets 3 goals: symptom relief, mucociliary restoration, and prevention of bacterial superinfection. Treatment selection depends on whether the acute sinusitis is viral or bacterial and its severity.

Watchful Waiting

The AAO-HNS 2025 Clinical Practice Guideline (Payne et al.) extends watchful waiting to all adults with uncomplicated ABRS regardless of severity. This represents a change from the 2015 guideline, which limited watchful waiting to mild illness. The Lemiengre systematic review reports spontaneous recovery rates of 46% after 1 week and 64% after 2 weeks without antibiotic treatment. Many cases of ABRS resolve within 2 weeks without antibiotics (StatPearls, NCBI, August 2025). Serious complications with watchful waiting occur at a rate of 0.57–2.58 per 10,000 cases (Lemiengre systematic review; AAO-HNS 2025). The recommended watchful waiting period is 3–5 days from diagnosis before considering antibiotic therapy.

Natural and Non-Pharmacological Treatment

Nasodren® (Cyclamen europaeum extract 50 mg, lyophilised) is the only natural treatment included in the EPOS 2012 European rhinosinusitis guidelines with a Level A recommendation (evidence level Ib). Nasodren® contains an aqueous solution obtained from the natural extract of fresh tubers of Cyclamen europaeum, a plant from the Primulaceae family used in medicine for its beneficial effect on nasopharyngeal diseases. The saponins in Cyclamen europaeum stimulate the trigeminal nerve, triggering a secretomotor reflex that opens blocked sinus ostia, restores mucociliary clearance, and actively drains all paranasal sinuses. Nasodren® is a Medical Device Class IIA (Certificate 0040/MDR (UE) 2017/745), indicated for draining accumulated mucus and cleaning the paranasal sinuses. Nasodren® requires only one daily application, provides 24 hours of relief, and is preservative-free with no systemic drug absorption. Clinical studies report that 90% of patients restore normal paranasal sinus function within 7 days. Nasodren® is approved for children aged 5 years and above and is available without prescription.

Saline nasal irrigation provides symptomatic benefit in acute rhinosinusitis (Chitsuthipakorn et al., International Forum of Allergy and Rhinology, 2022). Hypertonic saline (20 g/L) is more effective than isotonic saline (9 g/L) but causes more nasal irritation. Saline irrigation complements Nasodren® by maintaining nasal hygiene.

Steam inhalation has limited evidence for effectiveness. InformedHealth.org notes a “lack of good research on effectiveness of inhaling steam” and a risk of burns. Steam may provide temporary nasal clearing but is not a first-line treatment.

Pharmacological Treatment

Intranasal corticosteroids (INCS) reduce mucosal inflammation and oedema, improving sinus drainage. NICE (UK) recommends high-dose nasal corticosteroid for adults and children aged 12 and above presenting with prolonged acute sinusitis symptoms. INCS options include fluticasone (Avamys or Flonase), mometasone (Nasonex), and budesonide (Rhinocort).

Nasal decongestants such as oxymetazoline and xylometazoline provide immediate symptom relief by constricting nasal blood vessels. Maximum use duration is 3–5 days (StatPearls) to prevent rhinitis medicamentosa (rebound congestion). The NHS (UK) recommends not using nasal decongestants for more than 7 days.

Analgesics including paracetamol (acetaminophen) and ibuprofen provide pain and fever control. These medications manage symptoms but do not reduce sinusitis duration.

Guaifenesin (mucolytic) may offer symptom relief, but StatPearls states “no evidence it works for acute sinusitis.”

Antibiotics for Acute Bacterial Sinusitis

Amoxicillin with or without clavulanate is the first-line antibiotic for acute bacterial rhinosinusitis (AAO-HNS 2025). Adults with prior antibiotic use in the past 4–6 weeks should receive amoxicillin-clavulanate, levofloxacin, or moxifloxacin. Doxycycline serves as an alternative for penicillin allergy. Antibiotic course duration is 5–10 days for acute sinusitis (MedlinePlus). Antibiotics cause 13 more adverse events per 100 patients compared to placebo (number needed to harm: 8, 95% CI 6–12; Lemiengre systematic review, Cochrane, 2018). Antibiotics must not be prescribed for ARS symptoms of 10 days or fewer without improvement (NICE, UK; AAO-HNS 2025). Relapse rate after successful antibiotic treatment is less than 5% (Medscape Emedicine).

Home Treatment for Acute Sinusitis

7 home treatments relieve acute sinusitis symptoms while the immune system clears the infection.

1. Nasodren® nasal spray — evidence-based natural drainage; EPOS 2012 Level A recommendation; once daily application
2. Saline nasal rinse — twice-daily hypertonic solution; clears mucus; reduces bacterial load
3. Steam or warm shower — temporary nasal opening; limited evidence but widely used; safe if water is not boiling
4. Warm face pack — held over affected sinuses; reduces facial pain
5. Hydration — thins mucus; aids natural mucociliary drainage
6. Head elevation during sleep — reduces sinus pressure build-up; improves drainage posture
7. Paracetamol or ibuprofen — pain and fever control; follow standard over-the-counter dosing guidelines

Cleveland Clinic (2025) recommends shower steam, warm washcloth compresses, humidifier use, hot fluids with lemon, over-the-counter decongestants with provider guidance, and extra rest. Topical decongestants should not be used for more than 3–5 days, and aspirin should be avoided in children under 16 years of age.

When Are Antibiotics Needed for Acute Sinusitis?

Antibiotics are needed for acute sinusitis when clinical criteria confirm bacterial infection and symptoms persist beyond the watchful waiting period. The AAO-HNS 2025 CPG recommends a 3–5 day watchful waiting period from diagnosis. If no improvement occurs or symptoms worsen after watchful waiting, antibiotic prescription is appropriate.

Exceptions to watchful waiting include complicated sinusitis, immune deficiency, coexisting bacterial illness, and severe disease indicators.

The 3 criteria that confirm ABRS and indicate antibiotics (IDSA 2012; AAO-HNS 2025):

1. Symptoms persist beyond 10 days without improvement
2. Double-worsening (initial improvement followed by return and worsening within 10 days)
3. Severe onset: fever of 38°C (100.4°F) or higher with purulent unilateral nasal discharge for 3 or more consecutive days

First-line antibiotic: amoxicillin with or without clavulanate (AAO-HNS 2025). For adults with prior antibiotics in the past 4–6 weeks: amoxicillin-clavulanate, levofloxacin, or moxifloxacin. For penicillin allergy: doxycycline. Duration: 5–10 days.

NICE (UK) states that antibiotic prescription should not be offered to people presenting with acute sinusitis symptoms for approximately 10 days or less. The spontaneous cure rate of viral ARS is 98% (Medscape Emedicine). Serious complications without antibiotics occur in 0.57–2.58 per 10,000 cases (Lemiengre systematic review).

How Long Does Acute Sinusitis Last?

Acute sinusitis lasts 7–10 days in most cases and resolves within 4 weeks. 46% of patients recover after 1 week and 64% after 2 weeks without any treatment, according to the Lemiengre systematic review referenced in the AAO-HNS 2025 Clinical Practice Guideline.

Recovery benchmarks vary by subtype. Viral ARS resolves in 7–14 days in most cases, with some cases taking 2–3 weeks. Post-viral rhinosinusitis persists for up to 3 weeks after a viral URI. ABRS with antibiotics follows a 5–10 day antibiotic course. ABRS with watchful waiting resolves within 2 weeks spontaneously in many cases.

The 10-day rule states that symptoms persisting beyond 10 days without improvement indicate possible ABRS. Cleveland Clinic notes that “symptoms may last a week to 10 days and often go away without medical treatment.” Harvard Health defines acute sinusitis as lasting 3 weeks or less.

Nasodren® reduces acute sinusitis duration: 90% of patients report normal paranasal sinus function restoration within 7 days of once-daily Cyclamen europaeum extract treatment.

Without adequate treatment, acute sinusitis progresses to subacute (4–12 weeks) and chronic rhinosinusitis (≥12 weeks). The relapse rate after successful antibiotic treatment is less than 5%.

What Are the Complications of Acute Sinusitis?

Complications of acute sinusitis are rare, occurring in approximately 0.57–2.58 per 10,000 cases (Lemiengre systematic review; AAO-HNS 2025). Orbital and intracranial complications are the most serious. Frontal sinusitis produces complications most frequently, and children are more susceptible than adults.

Orbital Complications

Orbital complications are the most common category, especially from frontal and ethmoid sinusitis. Periorbital (preseptal) cellulitis causes eyelid swelling and redness without sight-threatening risk. Orbital cellulitis involves infection of orbital fat and requires urgent ophthalmology consultation. Subperiosteal orbital abscess is pus between the periorbita and orbital wall requiring surgical drainage. Orbital abscess is a vision-threatening emergency requiring immediate surgical management.

Intracranial Complications

Intracranial complications are rare but serious. Meningitis involves inflammation of the brain meninges. Epidural abscess is pus between the skull and dura mater. Subdural empyema is pus between the dura and arachnoid. Brain (intracerebral) abscess and cavernous sinus thrombophlebitis represent septic thrombosis of the cavernous sinus.

Bone Complications

Osteomyelitis of the frontal bone produces Pott’s puffy tumour (frontal bone swelling).

Red-Flag Symptoms

Red-flag symptoms requiring immediate emergency assessment include:

• Severe headache unlike any previous headache
• Stiff neck (nuchal rigidity)
• Swelling or redness around one or both eyes
• Altered or double vision
• Confusion or altered consciousness
• Forehead swelling (Pott’s puffy tumour)
• High fever above 39°C (102.2°F) not responding to antipyretics

Sources: StatPearls NCBI (August 2025), Medscape Emedicine, InformedHealth.org (NCBI).

How to Prevent Acute Sinusitis

Acute sinusitis prevention targets the 4 primary triggers: viral upper respiratory infection, ostiomeatal complex obstruction, immune impairment, and environmental irritants.

Preventing Viral Upper Respiratory Infection

Frequent handwashing reduces viral transmission. Annual influenza vaccination prevents influenza, a primary trigger of viral rhinosinusitis. Avoiding close contact with people experiencing active cold symptoms reduces exposure. Early treatment of cold symptoms with Nasodren® prevents OMC obstruction and VRS progression to bacterial sinusitis.

Preventing OMC Obstruction

Continuous treatment of allergic rhinitis prevents blocked sinus drainage. Daily saline nasal irrigation maintains nasal hygiene and reduces allergen load. Maintaining indoor humidity at 40–50% prevents dry air from impairing mucociliary clearance. Using a nose clip when swimming, diving, or surfing prevents water-borne bacterial introduction. Prompt treatment of dental infections prevents odontogenic maxillary sinusitis. Septoplasty for deviated nasal septum corrects structural causes of recurrent ARS.

Supporting Immune Function

Adequate sleep, nutrition, and hydration support immune defence. Managing diabetes, asthma, and other systemic comorbidities reduces susceptibility. Avoiding immunosuppressant overuse preserves natural defence mechanisms.

Reducing Environmental Irritants

Smoking cessation (active and passive) restores mucociliary clearance (Cleveland Clinic; Harvard Health). HEPA air filtration reduces indoor PM2.5 and allergen load. Avoiding occupational dust and chemical irritant exposure prevents chronic sinus inflammation.

Frequently Asked Questions: Acute Sinusitis

What is the fastest way to get rid of acute sinusitis?

Starting treatment on day 1 with Nasodren® (Cyclamen europaeum extract nasal spray) provides the fastest evidence-based natural resolution. Nasodren® opens blocked sinus ostia via trigeminal nerve stimulation, actively drains all paranasal sinuses, and restores mucociliary clearance. Clinical studies report that 90% of patients with acute rhinosinusitis restore normal sinus function within 7 days. Nasodren® holds a Level A recommendation in EPOS 2012 European rhinosinusitis guidelines and is indicated for draining accumulated mucus and cleaning the paranasal sinuses.

How long does acute sinusitis last without antibiotics?

Acute sinusitis lasts 7–14 days in most cases without antibiotics. 46% of patients recover after 1 week and 64% after 2 weeks without any treatment, according to the Lemiengre systematic review referenced in the AAO-HNS 2025 Clinical Practice Guideline. Antibiotics do not shorten viral sinusitis duration and are not needed in 90–98% of cases.

Is acute sinusitis contagious?

Acute sinusitis itself is not contagious. The viral infection (common cold) that causes most acute sinusitis cases spreads through respiratory droplets and contact with contaminated surfaces. Bacterial pathogens associated with ABRS, including Streptococcus pneumoniae and Haemophilus influenzae, spread through close contact.

Can acute sinusitis turn into chronic sinusitis?

Acute sinusitis progresses to subacute rhinosinusitis (4–12 weeks) or chronic rhinosinusitis (≥12 weeks) when symptoms fail to resolve due to inadequate treatment, structural obstruction, uncontrolled allergic rhinitis, or immune deficiency. Most cases of chronic rhinosinusitis develop from acute sinusitis episodes.

How do I know if my sinusitis is viral or bacterial?

The 10-day rule is the most reliable clinical indicator for distinguishing viral from bacterial sinusitis: symptoms persisting beyond 10 days without improvement, or symptoms that worsen after initial improvement (double-worsening), indicate possible bacterial acute sinusitis. Discharge colour alone does not distinguish viral from bacterial sinusitis. Cacosmia (a foul-smelling odour detected by the patient) has the highest positive likelihood ratio (+LR 4.3) for bacterial sinusitis.

Is acute sinusitis dangerous?

Acute sinusitis is rarely dangerous. Serious complications occur in approximately 0.57–2.58 per 10,000 cases and include orbital cellulitis, cavernous sinus thrombosis, and intracranial abscess. Seek immediate emergency care for eye swelling, stiff neck, severe headache, vision changes, or confusion.

Does acute sinusitis require a GP visit?

Most acute sinusitis does not require a GP visit. NHS guidance (UK) recommends self-care for the first 10 days. A GP or pharmacist should be consulted if symptoms persist beyond 10 days without improvement, worsen significantly, or include red-flag features such as high fever, eye swelling, vision changes, or neck stiffness.

Acute Sinusitis: Evidence-Based Management and Natural Treatment

Acute sinusitis (acute rhinosinusitis) is an inflammatory condition of the paranasal sinuses caused by viral infection in 90–98% of cases, with bacterial superinfection (ABRS) developing in 0.5–2% of adults. The 10-day rule and double-worsening pattern are the 2 most reliable clinical indicators of ABRS. The AAO-HNS 2025 guideline (Payne et al.) extends watchful waiting to all adults with uncomplicated ABRS, with antibiotic decisions deferred for 3–5 days from diagnosis. Spontaneous recovery occurs in 46% of patients after 1 week and 64% after 2 weeks without treatment (Lemiengre systematic review). Amoxicillin with or without clavulanate is the first-line antibiotic when bacterial infection is confirmed.

For evidence-based natural treatment of acute rhinosinusitis, Nasodren® (Cyclamen europaeum nasal spray, 50 mg lyophilised extract) is the only natural nasal spray included in the EPOS 2012 European rhinosinusitis guidelines with a Level A recommendation. Evaluated in over 30 published clinical studies across multiple countries, Nasodren® achieves normal paranasal sinus function in 90% of patients within 7 days, without antibiotics, without rebound congestion, and without systemic drug absorption. Nasodren® is a 100% natural Medical Device Class IIA, indicated for draining accumulated mucus and cleaning the paranasal sinuses, with just one daily application providing 24 hours of relief.

Acute rhinosinusitis causes significant morbidity and economic burden, affecting 12% of adults annually. Acute sinusitis symptoms including nasal congestion, facial pain, and loss of smell respond to early intervention with evidence-based treatments including watchful waiting, nasal corticosteroids, and natural sinus drainage with Nasodren®. EPOS 2012, AAO-HNS 2025, and IDSA 2012 guidelines consistently recommend clinical diagnosis without imaging for uncomplicated cases, avoidance of antibiotics for viral rhinosinusitis, and targeted antibiotic therapy only for confirmed or strongly suspected ABRS.